New SueWallSt Podcast Episode: Levi & Korsinsky Breaks Down Sarepta Therapeutics, Inc. Case


Press Release Date 08-13-2025

NEW YORK, NY / ACCESS Newswire / August 13, 2025 / Levi & Korsinsky, LLP releases a Podcast regarding Sarepta Therapeutics, Inc. (NASDAQ:SRPT) class action securities lawsuit

A Class Action lawsuit was filed on behalf of Sarepta Therapeutics, Inc. investors who lost money as a result of alleged securities fraud between June 22, 2023 and June 24, 2025.

Levi & Korsinsky has released a Podcast describing the nature of the action. The podcast for this class action lawsuit can be found here:

https://www.podbean.com/player-v2/?i=3paj8-1929c7d-pb&from=pb6admin&pbad=0&share=1&download=1&rtl=0&fonts=Arial&skin=1&font-color=auto&logo_link=episode_page&btn-skin=7

The filed complaint alleges that defendants made false statements and/or concealed that: (i) ELEVIDYS, a prescription gene therapy for Duchenne, posed significant safety risks to patients; (ii) ELEVIDYS trial regimes and protocols failed to detect severe side effects; (iii) the severity of adverse events from ELEVIDYS treatment would cause the Company to halt recruitment and dosing in ELEVIDYS trials, attract regulatory scrutiny, and create greater risk around the therapy's present and expanded approvals; and (iv) as a result of the foregoing, defendants materially misled with, and/or lacked a reasonable basis for, their positive statements.

If you have any questions about this class action lawsuit or any other sudden or unexpected stock loss, feel free to contact Levi & Korsinsky at (212)-363-7500.

You can also find recent podcasts regarding other class actions lawsuits and topics which are of interest to shareholders that have lost money in the stock market, here:

https://bullsandbetrayal.podbean.com/

LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
https://zlk.com/

SOURCE: Levi & Korsinsky, LLP

View the original press release on ACCESS Newswire

 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters